Blog Posts

REMINDER: REBATE RULE WOULD DO NOTHING TO LOWER DRUG PRICES WHILE HIKING PREMIUMS ON SENIORS AND COSTING TAXPAYERS $200 BILLION

Nov 16, 2020

Administration Should Abandon Misguided Policy That Rewards Drug Companies’ Read More

BIG PHARMA EARNINGS WATCH: ABBVIE, ASTRAZENECA & BRISTOL-MYERS SQUIBB

Nov 5, 2020

Big Pharma Completes Sweep of Beating Wall Street Expectations After 2020 Read More

BIG PHARMA EARNINGS WATCH: AMGEN & SANOFI

Nov 5, 2020

Big Pharma Giant Sees Profits Jump After July Price Hikes Big Pharma giants Read More

BIG PHARMA EARNINGS WATCH: GLAXOSMITHKLINE

Oct 29, 2020

Brand Name Big Pharma Giant Surpasses Expectations After Hiking Prices A new Read More

BIG PHARMA EARNINGS WATCH: MERCK, NOVARTIS & PFIZER

Oct 28, 2020

Brand Name Drug Companies Beat Wall Street Expectations After Repeatedly Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Oct 13, 2020

Price Hikes Fuel Q3 Earnings Beat For Brand Name Giant As millions of Read More

SECOND OPINION: PHARMA-BACKED REBATE RULE WOULD INCREASE OOP COSTS AND PREMIUMS FOR SENIORS — DO NOTHING TO LOWER RX PRICES

Oct 5, 2020

Big Pharma Claims Misguided Proposal Would Benefit Patients, Facts Show It Read More

DOSE OF REALITY: LAWMAKERS RIGHT TO TRAIN RENEWED FOCUS ON BIG PHARMA’S PRICE-GOUGING AND ANTI-COMPETITIVE TACTICS

Sep 29, 2020

Brand Name Drug Companies Must be Held Accountable for Pandemic Price Hikes Read More

DOSE OF REALITY: TRUMP ADMINISTRATION MUST DUMP REBATE RULE TO ACHIEVE SECOND TERM GOAL OF LOWERING PREMIUMS

Aug 26, 2020

Misguided Measure Would Increase Medicare Part D Premiums, Cost Taxpayers More Read More

DOSE OF REALITY: DEBUNKING BIG PHARMA’S SUPPLY CHAIN BLAME GAME

Aug 14, 2020

Drug Companies Target PBMs and Rebates That Play a Critical Role in Lowering Read More